Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of patents in the Cancer immunotherapy industry

Patents where

Current Assignee

Industry

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10071148 Immunotherapy against several tumors, such as lung cancer, including NSCLC	Patent 10071148 was granted and assigned to Immatics Biotechnologies on September, 2018 by the United States Patent and Trademark Office.		Immatics Biotechnologies	United States Patent and Trademark Office	10071148	September 11, 2018
‌ US Patent 11434274 Peptides and combination of peptides for use in immunotherapy against various tumors	Patent 11434274 was granted and assigned to Immatics Biotechnologies on September, 2022 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11434274	September 6, 2022
‌ US Patent 12091777 Variant nucleic acid libraries for CRTH2	Patent 12091777 was granted and assigned to Twist Bioscience on September, 2024 by the United States Patent and Trademark Office.	Twist Bioscience	Twist Bioscience	United States Patent and Trademark Office	12091777	September 17, 2024
‌ US Patent 12119091 Utilizing masked autoencoder generative models to extract microscopy representation autoencoder embeddings	Patent 12119091 was granted and assigned to Recursion Pharmaceuticals on October, 2024 by the United States Patent and Trademark Office.	Recursion Pharmaceuticals	Recursion Pharmaceuticals	United States Patent and Trademark Office	12119091	October 15, 2024
‌ US Patent 10416366 Light diffusing devices for use in photoimmunotherapy	Patent 10416366 was granted and assigned to Rakuten Medical on September, 2019 by the United States Patent and Trademark Office.	Rakuten Medical	Rakuten Medical	United States Patent and Trademark Office	10416366	September 17, 2019
‌ US Patent 11559550 Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers	Patent 11559550 was granted and assigned to Immatics Biotechnologies on January, 2023 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11559550	January 24, 2023
‌ US Patent 10980868 VEGFR-2 targeting immunotherapy approach	Patent 10980868 was granted and assigned to Vaximm on April, 2021 by the United States Patent and Trademark Office.	Vaximm	Vaximm	United States Patent and Trademark Office	10980868	April 20, 2021
‌ US Patent 11787864 Heterodimeric Fc-fused proteins	Patent 11787864 was granted and assigned to Dragonfly Therapeutics, Inc. on October, 2023 by the United States Patent and Trademark Office.	Dragonfly Therapeutics, Inc.	Dragonfly Therapeutics, Inc.	United States Patent and Trademark Office	11787864	October 17, 2023
‌ US Patent 11583536 Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use	Patent 11583536 was granted and assigned to Celgene on February, 2023 by the United States Patent and Trademark Office.	Celgene	Celgene	United States Patent and Trademark Office	11583536	February 21, 2023
‌ US Patent 11423256 Biological image transformation using machine-learning models	Patent 11423256 was granted and assigned to Insitro on August, 2022 by the United States Patent and Trademark Office.	Insitro	Insitro	United States Patent and Trademark Office	11423256	August 23, 2022
‌ US Patent 9770406 Medicament for the treatment of viral skin and tumour diseases	Patent 9770406 was granted and assigned to MediGene on September, 2017 by the United States Patent and Trademark Office.		MediGene	United States Patent and Trademark Office	9770406	September 26, 2017
‌ US Patent 11541107 Peptides and T cells for use in immunotherapeutic treatment of various cancers		Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11541107	January 3, 2023
‌ US Patent 11547750 Peptides and T cells for use in immunotherapeutic treatment hepatocellular carcinoma	Patent 11547750 was granted and assigned to Immatics Biotechnologies on January, 2023 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11547750	January 10, 2023
‌ US Patent 11344709 Fluid delivery apparatus having a controller assembly and method of use		Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	11344709	May 31, 2022
‌ US Patent 11648276 Immunotherapy against neuronal and brain tumors	Patent 11648276 was granted and assigned to Immatics Biotechnologies on May, 2023 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11648276	May 16, 2023
‌ US Patent 11559572 Peptides and T cells for use in immunotherapeutic treatment of various cancers		Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11559572	January 24, 2023
‌ US Patent 11576954 Method for treating non-small lung cancer with a population of activated cells		Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11576954	February 14, 2023
‌ US Patent 11562103 Nucleic acid based data storage	Patent 11562103 was granted and assigned to Twist Bioscience on January, 2023 by the United States Patent and Trademark Office.	Twist Bioscience	Twist Bioscience	United States Patent and Trademark Office	11562103	January 24, 2023
‌ US Patent 10046037 Immunotherapy against several tumors including neuronal and brain tumors	Patent 10046037 was granted and assigned to Immatics Biotechnologies on August, 2018 by the United States Patent and Trademark Office.		Immatics Biotechnologies	United States Patent and Trademark Office	10046037	August 14, 2018
‌ US Patent 10047123 Immunotherapy against several tumors including neuronal and brain tumors	Patent 10047123 was granted and assigned to Immatics Biotechnologies on August, 2018 by the United States Patent and Trademark Office.		Immatics Biotechnologies	United States Patent and Trademark Office	10047123	August 14, 2018
‌ US Patent 10047124 Immunotherapy against several tumors including neuronal and brain tumors	Patent 10047124 was granted and assigned to Immatics Biotechnologies on August, 2018 by the United States Patent and Trademark Office.		Immatics Biotechnologies	United States Patent and Trademark Office	10047124	August 14, 2018
‌ US Patent 11040183 Receptacle portion of transdermal drug delivery apparatus and methods	Patent 11040183 was granted and assigned to Sorrento Therapeutics on June, 2021 by the United States Patent and Trademark Office.	Sorrento Therapeutics	Sorrento Therapeutics	United States Patent and Trademark Office	11040183	June 22, 2021
‌ US Patent 11566230 Universal donor cells	Patent 11566230 was granted and assigned to CRISPR Therapeutics on January, 2023 by the United States Patent and Trademark Office.	CRISPR Therapeutics	CRISPR Therapeutics	United States Patent and Trademark Office	11566230	January 31, 2023
‌ US Patent 11401338 Antibodies against signal-regulatory protein alpha and methods of use	Patent 11401338 was granted and assigned to ALX Oncology on August, 2022 by the United States Patent and Trademark Office.	ALX Oncology	ALX Oncology	United States Patent and Trademark Office	11401338	August 2, 2022
‌ US Patent 11639376 Constructs having a SIRP-α domain or variant thereof	Patent 11639376 was granted and assigned to ALX Oncology on May, 2023 by the United States Patent and Trademark Office.	ALX Oncology	ALX Oncology	United States Patent and Trademark Office	11639376	May 2, 2023

...

Results per page:

1,211 results

0 selected

1,211 results

0 selected